Detalhe da pesquisa
1.
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
Circulation
; 147(16): 1192-1203, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779348
2.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med
; 384(2): 105-116, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185990
3.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail
; 30(1): 26-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683911
4.
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease.
Circulation
; 146(15): 1109-1119, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031810
5.
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients.
Cardiovasc Drugs Ther
; 37(4): 743-755, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460392
6.
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.
Eur Heart J
; 43(48): 5006-5016, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675469
7.
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations.
Br J Clin Pharmacol
; 88(1): 187-198, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131942
8.
Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator.
Biopharm Drug Dispos
; 42(7): 319-328, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34087948
9.
Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.
Circulation
; 134(5): 378-91, 2016 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27482002
10.
Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry.
Cardiovasc Diabetol
; 16(1): 14, 2017 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122619
11.
Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
J Cardiovasc Magn Reson
; 19(1): 107, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29284499
12.
Right Ventricular Fibrosis Is Related to Pulmonary Artery Stiffness in Pulmonary Hypertension: A Cardiac Magnetic Resonance Imaging Study.
Am J Respir Crit Care Med
; 200(6): 776-779, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31144985
13.
Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease.
Circulation
; 128(6): 605-14, 2013 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23804252
14.
Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function.
Am Heart J
; 167(4): 620-6, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24655713
15.
Role of cardiac MRI in diabetes.
Curr Cardiol Rep
; 16(2): 449, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24430012
16.
Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance.
J Cardiovasc Magn Reson
; 15: 52, 2013 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23767423
17.
Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients.
J Cardiovasc Magn Reson
; 15: 89, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24083836
18.
Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects.
Clin Pharmacol Drug Dev
; 11(1): 129-133, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272833
19.
Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects.
Clin Pharmacol Drug Dev
; 11(3): 388-396, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34634185
20.
Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug-Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open-Label Studies in Healthy Subjects.
Clin Pharmacol Drug Dev
; 11(2): 185-193, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145992